QSAR: dead or alive?

Journal of Computer-aided Molecular Design
Arthur M Doweyko

Abstract

This perspective concerns the methods employed within the current drug discovery community to develop predictive quantitative structure-activity relationships (QSAR). Specifically, a number of cautions are provided which may circumvent misuse and misunderstanding of the technique. Ignorance of such caveats has led to a discouraging tendency of the methods to result in poorly predictive models. Among these pitfalls are the fondness with which we associate correlation with causation, the mesmerizing influence of large numbers of molecular descriptors, the incessant misuse of the leave-one-out paradigm, and finally, the QSAR enigma wherein model predictivity is not a necessary component of a model's usefulness.

References

Oct 1, 1979·Journal of Medicinal Chemistry·J G Topliss, R P Edwards
Feb 1, 1989·The American Journal of Cardiology·G A Diamond
Mar 1, 1994·Protein Engineering·J AqvistJ E Samuelsson
Sep 29, 2000·Journal of Computer-aided Molecular Design·S GuccioneF Balzano
Feb 23, 2002·Journal of Molecular Graphics & Modelling·Alexander Golbraikh, Alexander Tropsha
Jul 23, 2003·Current Pharmaceutical Design·John H van Drie
Aug 20, 2003·Environmental Toxicology and Chemistry·John D WalkerJohn C Dearden
Jul 1, 1964·Journal of Medicinal Chemistry·S M FREE, J W WILSON
Nov 24, 2004·Journal of Chemical Information and Computer Sciences·Robert P SheridanSimon K Kearsley
Feb 26, 2005·Journal of Computer-aided Molecular Design·Arthur M Doweyko
Apr 22, 2005·Perspectives in Biology and Medicine·Stephen Stigler
Jul 25, 2006·Journal of Chemical Information and Modeling·Gerald M Maggiora
Sep 29, 2006·Journal of Medicinal Chemistry·Gregory L WarrenMartha S Head
Mar 7, 2007·European Journal of Internal Medicine·Elyiahu StoupelDaniela Harell
Aug 25, 2007·Journal of Basic and Clinical Physiology and Pharmacology·Elyiahu StoupelNechama Linder
Aug 1, 1988·Journal of the American Chemical Society·R D CramerJ D Bunce

❮ Previous
Next ❯

Citations

Sep 12, 2008·Journal of Computer-aided Molecular Design·Rajarshi Guha
Dec 14, 2011·Journal of Computer-aided Molecular Design·Peter W Kenny
Mar 19, 2013·Journal of Computer-aided Molecular Design·David J WoodJonna Stålring
Oct 22, 2013·Journal of Computer-aided Molecular Design·Gergely TóthKároly Héberger
Jun 25, 2010·Journal of Chemical Information and Modeling·Denis FourchesAlexander Tropsha
Aug 8, 2009·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Laura K ChicoD Martin Watterson
Jan 19, 2012·Journal of Computer-aided Molecular Design·G SeddonG Vriend
Sep 7, 2013·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Qian ChenXiaohui Fan
Jul 16, 2011·Expert Opinion on Drug Metabolism & Toxicology·Robert D Combes
Jan 13, 2016·Journal of Chemical Information and Modeling·Toshio Fujita, David A Winkler
Aug 17, 2010·Drug Discovery Today·Pier G De Benedetti, Francesca Fanelli
Oct 30, 2015·Environmental Science & Technology·Patrik John Gustav HenrikssonJeroen Guinee
Dec 17, 2014·Journal of Chemical Information and Modeling·Robert FraczkiewiczAlexander Hillisch
Nov 26, 2008·Drug Discovery Today·John Delaney
Jun 10, 2011·Journal of Computational Chemistry·A P ToropovaJ Leszczynski
Dec 1, 2011·Molecular Informatics·David J WoodSarah L Rodgers
Dec 17, 2010·Molecular Informatics·Fiorella RuggiuDragos Horvath
Apr 1, 2012·Molecular Informatics·Eugene N MuratovVictor E Kuz'min
Mar 26, 2011·Chemical Biology & Drug Design·Emilio BenfenatiRodolfo Gonella Diaza
May 30, 2009·Journal of Computational Chemistry·Andrey A ToropovJerzy Leszczynski
Jul 12, 2010·Molecular Informatics·Alexander Tropsha
Oct 5, 2014·Drug Discovery Today·Pier G De Benedetti, Francesca Fanelli
Nov 1, 2011·Journal of Chemical Information and Modeling·Michael C Hutter
Jul 16, 2011·Journal of Medicinal Chemistry·W Patrick WaltersMark A Murcko
Jan 19, 2013·Journal of Chemical Information and Modeling·Andrew D WhiteShaoyi Jiang
Jan 25, 2013·Journal of Chemical Information and Modeling·Christopher E KeeferRishi Raj Gupta
Mar 5, 2011·Molecular Pharmaceutics·Jianping Huang, Xiaohui Fan
Aug 4, 2012·Journal of Chemical Information and Modeling·Yunierkis Pérez-CastilloAnn Nowé
Jun 29, 2018·Future Medicinal Chemistry·Michael C Hutter
Jul 13, 2018·Expert Opinion on Drug Discovery·George Lambrinidis, Anna Tsantili-Kakoulidou
Aug 2, 2018·Toxicology Mechanisms and Methods·Andrey A Toropov, Alla P Toropova
Feb 7, 2019·Molecular Informatics·Alla P Toropova, Andrey A Toropov
Nov 30, 2013·Nature Reviews. Drug Discovery·John G CummingHongming Chen
Nov 9, 2019·Current Topics in Medicinal Chemistry·Alla P Toropova, Andrey A Toropov
Jul 29, 2020·Toxicology Mechanisms and Methods·Andrey A ToropovEmilio Benfenati
Feb 23, 2018·Frontiers in Pharmacology·Rodolfo S SimõesKathia M Honorio
Feb 28, 2013·Journal of Materials Chemistry. B, Materials for Biology and Medicine·D CunhaC Serre
Aug 15, 2009·Molecular Diversity·A A ToropovA Manganaro
Dec 20, 2012·Molecular Diversity·Jianping Huang, Xiaohui Fan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.